Nephros CFO Krandel gets two stock options, bonus target raised to 30%

NEPHROS INC

Amendment to CFO Judith Krandel's letter agreement grants options for 54,359 and 58,961 shares under 2024 Equity Incentive Plan.
First option vests 25% on first anniversary, then quarterly over 3 years; second vests upon closing a strategic transaction adding ≥$4M annual revenue.
Annual performance bonus target increased to 30% of base salary; options accelerate upon termination without cause.
Grant date is 3rd business day after filing 2024 10-K; exercise price equals closing price on grant date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.